抗体 >> 其他抗体
GSK-3结合蛋白FRAT2抗体
|
交货朞 1?/span>
索取资料及报件/span>
产品介绍
靶标9p style="text-indent: 2em;">FRAT2
产品别名9p style="text-indent: 2em;">FRAT-2 FRAT2 FRAT regulator of WNT signaling pathway 2 FRAT regulator of WNT signaling pathway 2 GSK-3-binding protein FRAT2 FRAT2, WNT signaling pathway regulator frequently rearranged in advanced T-cell lymphomas 2 GSK-3结合蛋白FRAT2 背景信息9div style="text-indent: 2em;">FRAT1 and FRAT2 were originally characterized as proteins frequently rearranged in advanced T cell lymphoma, and they have since been identified as proto-oncogenes involved in tumorigenesis. These proteins share significant homology with the Xenopus glycogen synthase kinase-3 (xGSK-3) binding protein, which is designated GBP and is essential for the formation of the dorsal-ventral axis during embryonic development. Establishment of these embryonic axes is mediated by the Wnt intracellular signaling pathway. Wnt signaling is regulated in part by the activity of GSK-3, which phosphorylates and thereby facilitates the degradation of ?catenin. GBP binds to GSK-3 and inhibits this phosphorylation, resulting in the accumulation of ?catenin and the subsequent transcription of Wnt target genes. Like GBP, FRAT2 has been shown to bind xGSK-3, suggesting that FRAT1 and FRAT2 may be GSK-3 regulatory proteins. 宿主:Rbt |
相关产品
|



